บทความที่มีข้อกำหนดการเข้าถึงสาธารณะ - Tadashi Yoshidaดูข้อมูลเพิ่มเติม
ไม่มีให้ใช้งานในทุกที่: 1
P. 1. i. 004 Characterization of conditioned fear-induced c-Fos and phosphorylated CREB-positive cells in the basolateral amygdala
T Izumi, T Inoue, K Konno, T Yamaguchi, T Yoshida, M Watanabe, ...
European Neuropsychopharmacology 19, S338, 2009
ข้อกำหนด: Science Foundation Ireland
มีให้ใช้งานในบางที่: 36
Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy
T Yoshida, P Delafontaine
Cells 9 (9), 1970, 2020
ข้อกำหนด: US National Institutes of Health, American Heart Association
Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia
T Yoshida, AM Tabony, S Galvez, WE Mitch, Y Higashi, S Sukhanov, ...
The international journal of biochemistry & cell biology 45 (10), 2322-2332, 2013
ข้อกำหนด: US National Institutes of Health
Angiotensin II, oxidative stress and skeletal muscle wasting
S Sukhanov, T Yoshida, AM Tabony, Y Higashi, S Galvez, P Delafontaine, ...
The American journal of the medical sciences 342 (2), 143-147, 2011
ข้อกำหนด: US National Institutes of Health
Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18
AJ Valente, T Yoshida, SN Murthy, SSVP Sakamuri, M Katsuyama, ...
American Journal of Physiology-Heart and Circulatory Physiology 303 (3 …, 2012
ข้อกำหนด: US National Institutes of Health
IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt-and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression
T Yoshida, L Semprun-Prieto, S Sukhanov, P Delafontaine
American Journal of Physiology-Heart and Circulatory Physiology 298 (5 …, 2010
ข้อกำหนด: US National Institutes of Health
Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK
JM Siddesha, AJ Valente, SSVP Sakamuri, T Yoshida, JD Gardner, ...
Journal of molecular and cellular cardiology 65, 9-18, 2013
ข้อกำหนด: US National Institutes of Health
Mechanisms of cachexia in chronic disease states
T Yoshida, P Delafontaine
The American journal of the medical sciences 350 (4), 250-256, 2015
ข้อกำหนด: US National Institutes of Health
Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1
AJ Valente, T Yoshida, JD Gardner, N Somanna, P Delafontaine, ...
Cellular signalling 24 (2), 560-568, 2012
ข้อกำหนด: US National Institutes of Health
Insulin-like growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6 expression and binding to the 5′ stem-loop of COL1a1 and …
CD Blackstock, Y Higashi, S Sukhanov, SY Shai, B Stefanovic, ...
Journal of Biological Chemistry 289 (11), 7264-7274, 2014
ข้อกำหนด: US National Institutes of Health
Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration
T Yoshida, S Galvez, S Tiwari, BM Rezk, L Semprun-Prieto, Y Higashi, ...
Journal of Biological Chemistry 288 (33), 23823-23832, 2013
ข้อกำหนด: US National Institutes of Health
Angiotensin II induced catabolic effect and muscle atrophy are redox dependent
LC Semprun-Prieto, S Sukhanov, T Yoshida, BM Rezk, ...
Biochemical and biophysical research communications 409 (2), 217-221, 2011
ข้อกำหนด: US National Institutes of Health
The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1 …
S Sukhanov, Y Higashi, T Yoshida, S Mummidi, AR Aroor, JJ Russell, ...
Cellular signalling 77, 109825, 2021
ข้อกำหนด: US National Institutes of Health, US Department of Veterans Affairs …
Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus
T Yoshida, L Semprun-Prieto, RD Wainford, S Sukhanov, DR Kapusta, ...
Endocrinology 153 (3), 1411-1420, 2012
ข้อกำหนด: US National Institutes of Health
Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy
P Shanmugam, AJ Valente, SD Prabhu, B Venkatesan, T Yoshida, ...
Journal of molecular and cellular cardiology 50 (6), 928-938, 2011
ข้อกำหนด: US National Institutes of Health
Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling
AJ Valente, T Yoshida, RA Clark, P Delafontaine, U Siebenlist, ...
Free Radical Biology and Medicine 60, 125-135, 2013
ข้อกำหนด: US National Institutes of Health
Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy
BM Rezk, T Yoshida, L Semprun-Prieto, Y Higashi, S Sukhanov, ...
PLoS One 7 (1), e30276, 2012
ข้อกำหนด: US National Institutes of Health
Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting
AM Tabony, T Yoshida, S Galvez, Y Higashi, S Sukhanov, ...
Hypertension 58 (4), 643-649, 2011
ข้อกำหนด: US National Institutes of Health
Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte death
T Yoshida, I Friehs, S Mummidi, PJ del Nido, S Addulnour-Nakhoul, ...
Journal of molecular and cellular cardiology 75, 141-151, 2014
ข้อกำหนด: US National Institutes of Health
The renin-angiotensin system and the biology of skeletal muscle: mechanisms of muscle wasting in chronic disease states
P Delafontaine, T Yoshida
Transactions of the American Clinical and Climatological Association 127, 245, 2016
ข้อกำหนด: US National Institutes of Health
แหล่งที่มาและข้อมูลกองทุนดำเนินการโดยโปรแกรมคอมพิวเตอร์โดยอัตโนมัติ